Latest Health News
- Obesity Gets the Buzz – but This Is a Bigger Health ThreatLearn why staying fit, not just slim, can boost your health and protect against serious diseases better than just watching your weight.
- Why Surgery May Not Be Needed for Low-Risk Breast CancerA lumpectomy plus radiation is very effective for treating stage zero cancer, but new research suggests that active monitoring may be just as good.
- FDA Approves New Treatment for StrokeThe FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.
- HHS Secretary RFK Jr. Urges Parents to Consider Measles ShotAmid a Texas measles outbreak that has reached just under 150 documented cases, U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is calling on all parents to discuss measles vaccination with their children’s health care providers.
- Why Step Count Remains the Most Impactful Fitness StatIncreasing daily movement, particularly through step count, may be the most effective measure for enhancing longevity and overall wellness.
- New ‘State-of-the-Science’ Test Can Reveal Risk of AddictionThe Comprehensive Addiction Risk Evaluation System, or CARES, uses your genetic information and details about your past – like childhood experiences, alcohol or substance use, and family history – to predict how likely you may be to have a substance use disorder.
- Flu Season Still Surging: 3 Key UpdatesExperts emphasize the importance of getting vaccinated against both influenza A and B strains to prevent serious health complications during the extended 2025 flu season.
- Even Amid Wildfire Devastation, Being Outside Helps Us HealResearch suggests that nature’s regeneration can provide solace to people traumatized by wildfires. And after the Los Angeles wildfires, residents see surviving trees as symbols of hope and recovery.
- Texas Confirms Outbreak's First Measles-Related DeathThe Texas Department of Health and Human Services says a school-age child who had been hospitalized in the West Texas town of Lubbock and was not vaccinated against measles has died in a measles outbreak.
- FDA Approves New Label for Opioid Use Disorder DrugThe FDA has approved a new treatment plan a long-acting injection called Sublocade, making it easier for people with moderate to severe opioid use disorder (OUD) to start and keep up with their treatment.
- Opioids and Surgery: How to Know Your Usage Risk Going InTalking to your doctor about pain management before surgery could make opioid addiction less likely, as a new study says that certain surgeries raise the chances of long-term opioid use, an addiction risk factor.
- FDA Approves New Treatment for Rare Lipid Storage DiseaseThe FDA has approved a new pill for adults with cerebrotendinous xanthomatosis (CTX), a rare genetic disease that makes it hard for the body to handle cholesterol properly.
- Measles Outbreaks in U.S. Are Growing: How to Protect YourselfMeasles cases surge in the United States, led by a significant outbreak in Texas, highlighting the need for increased MMR vaccination as recommended by the CDC.
- FDA OKs First Fast-Acting Insulin Biosimilar for Diabetes The FDA has approved Merilog, a new fast-acting insulin biosimilar for managing blood sugar in people with diabetes, marking the first such biosimilar to receive federal approval.
- Many Athletes With Heart Issues May Be Able to Play AgainNew guidelines recommend that decisions about sports participation for athletes with heart conditions should be made jointly by doctors and athletes, highlighting lower risks than previously understood.
- ‘Dangerous’ Hospital Bed Shortages on Horizon: What to KnowA new report anticipates a hospital bed shortage as soon as 2032. Here’s how that could impact you.
- New Studies Show RSV Vaccine Is Safe During PregnancyA vaccine for pregnant women protected babies from respiratory syncytial virus, the leading cause of infant hospitalization in the United States, giving researchers hope for widespread immunity against the disease.
- FDA Approves 5-in-1 Vaccine Against Meningococcal DiseaseThe FDA has approved Penmenvy, a new 5-in-1 shot to protect against meningococcal infections or invasive meningococcal disease (IMD) in people ages 10 to 25 years.
- FDA OKs Vaccine for Mosquito-Borne ChikungunyaThe FDA has approved Vimkunya, a first-of-its-kind shot to prevent the viral disease chikungunya in people 12 and older.
- FDA Approves New Drug for Rare Joint Tumor The FDA has approved vimseltinib, a new oral drug for a rare, noncancerous tumor of the joints known as tenosynovial giant cell tumor (TGCT). It is intended for adults with symptomatic TGCT when surgery could worsen their condition.
- Yogurt May Help Lower Your Colon Cancer Risk: StudyEating at least two servings of yogurt a week may help protect you from cancer in a particular part of the colon.
- How an Ongoing Erosion of Trust Damages Your Mental HealthDistrust of everything from institutions to people closest to you takes a serious toll on health and happiness. Here’s how to find a way back.
- Semaglutide Shows Promise for Cutting Alcohol UseA clinical trial shows that people who were considered by medical researchers to report signs of alcohol use disorder drank significantly less after taking semaglutide for two months, compared to people with similar alcohol habits who didn’t take the drug.
- FDA OKs Triple Combo for Advanced Large B-Cell LymphomaThe FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL).
- FDA Approves New Treatment for NF1-Related TumorsThe FDA has approved a pill for a rare disorder called neurofibromatosis type 1 (NF1). Mirdametinib, sold under the brand name Gomekli, is for adults and children ages 2 and older who have nerve tumors (plexiform neurofibromas) that cause symptoms and can't be fully removed with surgery.
Recommended